Sprintec and Weight increased for Women aged 20-29 (a phase IV clinical study of FDA data)

Summary:

Weight increased is found for women aged 20-29 who take Sprintec (ethinyl estradiol; norgestimate). This study is created by eHealthMe based on reports of 965 women aged 20-29 from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Sprintec when people have Weight increased
Top conditions
Top co-used drugs
Top other side effects

On Mar, 20, 2026

965 women aged 20-29 reported to have side effects when taking Sprintec.
Among them, 25 people (2.59%) have Weight increased

What is Sprintec?

Sprintec has active ingredients of ethinyl estradiol; norgestimate. It is often used in birth control. eHealthMe is studying from 4,397 Sprintec users. Check the latest studies of Sprintec.

What is Weight increased?

Weight increased is found to be associated with 2,898 drugs and 3,932 conditions by eHealthMe. Check the latest studies of Weight increased.

Number of reports submitted per year:

Could Sprintec cause Weight increased in women aged 20-29?

Time on Sprintec when people have Weight increased *

Severity of Weight increased

n/a

How people recovered from Weight increased

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Fibromyalgia (a long-term condition which causes pain all over the body): 4 people, 16.00%
Cushing's Syndrome (obesity, a rounded face, increased fat): 4 people, 16.00%
Stress And Anxiety: 3 people, 12.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 12.00%
Cystic Fibrosis (disease of the secretary glands): 2 people, 8.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 8.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.00%
Fabry's Disease (build up of a particular type of fat, called globotriaosylceramide, in the body's cells): 2 people, 8.00%
Seasonal Allergy (allergic condition due to certain season): 2 people, 8.00%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Nausea (feeling of having an urge to vomit): 9 people, 36.00%
Drug Ineffective: 7 people, 28.00%
Pain: 7 people, 28.00%
Fatigue (feeling of tiredness): 6 people, 24.00%
Nausea And Vomiting: 6 people, 24.00%
Amenorrhea (absence of a menstrual period in a woman of reproductive age): 6 people, 24.00%
Uterine Polyp (a mass in the inner lining of the uterus): 4 people, 16.00%
Uterine Enlargement: 4 people, 16.00%
Pain In Extremity: 4 people, 16.00%
Blood Potassium Decreased: 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sprintec and have Weight increased?

- Check whether Weight increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Sprintec and Weight increased

How the study uses the data?

The study is based on (applicable) gender, age, ethinyl estradiol; norgestimate (the active ingredients of Sprintec) and Sprintec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.